Embolization of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms with use of cyanoacrylate with or without coils.

Translumbar embolization was used to treat 11 type 2 endoleaks in nine patients with the liquid embolic agent n-butyl cyanoacrylate (NBCA). Nine of the embolizations were performed with a combination of stainless-steel coils and NBCAJ and the other two were performed with NBCA alone. There was complete occlusion on initial computed tomographic (CT) angiography in six of nine patients (66%), including the two cases treated with NBCA alone. Persistent endoleak on initial CT angiography occurred in three of nine patients (33%). Two of these patients underwent successful repeated embolization with NBCA. Aneurysm size remained unchanged in four patients (44%), decreased in four patients (44%), and increased in one patient (11%). No complications occurred. Initial results with the use of NBCA for endoleak embolization are encouraging.
AuthorsS William Stavropoulos, Hans Kim, Timothy W I Clark, Ronald M Fairman, Omaida Velazquez, Jeffrey P Carpenter
JournalJournal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) Vol. 16 Issue 6 Pg. 857-61 (Jun 2005) ISSN: 1051-0443 [Print] United States
PMID15947050 (Publication Type: Journal Article)
Chemical References
  • Cyanoacrylates
  • Tissue Adhesives
  • Bucrylate
  • Aged
  • Aged, 80 and over
  • Aortic Aneurysm, Abdominal (radiography, therapy)
  • Bucrylate (therapeutic use)
  • Cyanoacrylates (administration & dosage)
  • Embolization, Therapeutic (instrumentation, methods)
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Tissue Adhesives (therapeutic use)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: